TNYA has been in consolidation the past two days being in the flag of
a bull flag pattern on the 1H chart. Earnings about six weeks ago were
solid especially for a biotechnology stock which are generally priced
based on future potential and not current performance.
( Fundamentally TNYA is in the gene splicing /slicing place which is
perhaps the most lucrative and therapeutic of all of the various
areas in the biotechnology realm. Seemingly, its potential is
expodentially high. )
The zero lag MACD lines have crossed under the histogram which in
general can be considered as a buy signal. The histogram has flipped to
positive.
Upside to the overhead resistance zone by the Luxalgo indicator
is from an entry of about 5 to 6 or about 20%.
Very recent high relative volume as compared with
the 50 day moving average further supports a long trade at this
time. The stop loss would be $.02 below the POC line of the
volume profile.
I will play this with options to further leverage the price action.
Both options and stock are inexpensive for a small account.
a bull flag pattern on the 1H chart. Earnings about six weeks ago were
solid especially for a biotechnology stock which are generally priced
based on future potential and not current performance.
( Fundamentally TNYA is in the gene splicing /slicing place which is
perhaps the most lucrative and therapeutic of all of the various
areas in the biotechnology realm. Seemingly, its potential is
expodentially high. )
The zero lag MACD lines have crossed under the histogram which in
general can be considered as a buy signal. The histogram has flipped to
positive.
Upside to the overhead resistance zone by the Luxalgo indicator
is from an entry of about 5 to 6 or about 20%.
Very recent high relative volume as compared with
the 50 day moving average further supports a long trade at this
time. The stop loss would be $.02 below the POC line of the
volume profile.
I will play this with options to further leverage the price action.
Both options and stock are inexpensive for a small account.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.